Clinical Trials Browser

OTHER × envafolimab × Head & Neck × Clear all

NCT06059261 2026-02-18

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Phase 2 Recruiting

Nasopharyngeal Carcinoma